Integrated Sales Systems Ltd, a UK customer relationship management firm specializing in the pharmaceuticals and financial services markets, intends to expand it operations across Europe, concentrating initially in Germany. The firm, which had revenue of around $7.8m last year, is already present in Germany, Spain and France, but sees Germany as the key European market. ISS received venture capital from Kennett Capital and Galileo worth $5.6m last October which will fund this growth. At the CRM conference in London yesterday, ISS released Oxygen Pharma 4.1, a packaged version of its CRM for pharmaceutical firms which it claims will allow quicker implementation.
